Conduct / Assessment of BE [Design Issues]

posted by joyjac – Philippines, 2006-05-23 05:50 (7338 d 14:07 ago) – Posting: # 134
Views: 11,333

Dear HS,

How would you conduct/assess BE of 2 drug products of the same active ingredient but of different dosage formats and strengths i.e. immediate-release, 130 mg per tablet versus sustained-release, 200 mg per tablet? Thanks.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
161 visitors (0 registered, 161 guests [including 32 identified bots]).
Forum time: 19:57 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5